These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38158617)

  • 1. Rectal cancer - avoiding surgery?
    Leite JS
    Colorectal Dis; 2024 Feb; 26(2):383-385. PubMed ID: 38158617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 3. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
    Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
    Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
    Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
    Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
    Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
    JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
    van der Valk MJM; Hilling DE; Bastiaannet E; Meershoek-Klein Kranenbarg E; Beets GL; Figueiredo NL; Habr-Gama A; Perez RO; Renehan AG; van de Velde CJH;
    Lancet; 2018 Jun; 391(10139):2537-2545. PubMed ID: 29976470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
    Dossa F; Chesney TR; Acuna SA; Baxter NN
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis.
    Ferri V; Vicente E; Quijano Y; Duran H; Diaz E; Fabra I; Malave L; Ruiz P; Costantini G; Pizzuti G; Cubillo A; Rubio MC; Cañamaque LG; Alfonsel JN; Caruso R
    Int J Colorectal Dis; 2023 Dec; 38(1):277. PubMed ID: 38051359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 14. Watch and Wait for rectal cancer in inflammatory bowel disease.
    Azevedo JGM; Fernandez L; Herrando AI; Santiago I; Pares O; Parvaiz A
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
    Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
    JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
    Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
    [No Abstract]   [Full Text] [Related]  

  • 18. A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers.
    Langheinrich M; Paasch C; Mantke R; Weber K; Benz S; Kersting S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12591-12596. PubMed ID: 37438538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
    Wang QX; Zhang R; Xiao WW; Zhang S; Wei MB; Li YH; Chang H; Xie WH; Li LR; Ding PR; Chen G; Zeng ZF; Wang WH; Wan XB; Gao YH
    Radiat Oncol; 2021 Jan; 16(1):16. PubMed ID: 33468176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.